This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Last month, xAI and Anthropic raised a combined $9 billion as AI funding remained red-hot. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. Other sectors, including IT management and robotics, also saw big rounds.
Of course, it was led by two well-known AI startups — including xAI , which had its second massive haul of cash in just six months. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. The immediate investment was $1.25
Stability AI , the venture-backed startup behind the text-to-image AI system Stable Diffusion, is funding a wide-ranging effort to apply AI to the frontiers of biotech. Few groups have the engineering expertise and resources necessary to develop this kind of AI, though.
Not surprisingly AI led the way — as it always seems to do — with a trio of a billion-or-more rounds. xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI.
A proposed California bill that has proven controversial in the industry is looking to put safety regulations and guardrails on AI — although many companies, including OpenAI, worry it may be too burdensome to many AI firms. Sakana AI locked up a $100 million round led by Khosla Ventures , Lux Capital and New Enterprise Associates.
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note.
xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI, officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI. Grok is trained off data from another Musk-owned company, X, formerly Twitter.
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Pathalys Pharma , $105M, biotech: Raleigh, North Carolina-based Pathalys Pharma isn’t new to this list — it topped it early last year. Another slow week with only three companies raising rounds of more than $100 million.
You had to raise more than $150 million to make the top 10 list this month — as investors put money into everything from defense tech to semiconductors to biotech. GondolaBio , $300M, biotech: BridgeBio Pharma spun off GondolaBio this month, a biotech focused on early-stage genetic disease treatments.
Converge Bio, a generativeAI platform for accelerated drug discovery and development, announced on Wednesday that it has raised $5.5 million in Seed funding, led by TLV Partners. in Seed funding to speed up drug discovery and development with GenAI appeared first on OODAloop.
As part of the deal, Anthropic will now use Amazon Web Services data centers, as well as AWS Trainium and Inferentia chips to build, train and deploy its models. Founded in 2021, the generativeAI platform is a competitor to other AI firms such as OpenAI and Google. The immediate investment is $1.25 billion in June.
The company offers cloud computing services and hardware for training artificial intelligence software. The startup is a provider of Nvidia ’s latest GPUs, which are highly sought after by AI developers. Freenome , $254M, biotech: This is just one of many big biotech raises this month. billion valuation.
An AI platform enabling pharma and biotech companies to design new drugs more easily ReLeaf Paper Turns fallen tree leaves into paper and sustainable packaging. Respeecher Respeecher, AI voice generation startup used to create the Darth Vader AI voice in the Star War’s TV series – Obi-Wan Kenobi – and during the war!
General Catalyst led two big rounds last month, which included a $150 million Series C for AI-powered coding assistant Codeium that values the Mountain View, California-based startup at $1.25
The San Jose, California-based firm, which is developing its AI inference chip for both the generativeAI and automotive industries, raised a $102 million Series C co-led by Celesta Capital and GreatPoint Ventures.
They proceeded to use another set of AI models to identify molecules which could disrupt the activity of the target protein. This second step involved the relatively new type of AI that is called generativeAI. These are familiar to us all from ChatGPT and GPT-4: GPT stands for Generative Pre-trained Transformer.
For example, I recently talked with the CEO of a biotech investment fund. As a field, biotech has been a leader in applying machine learning (think protein folding); and it’s not clear whether generativeAI tools will contribute much to core business of biotech. RedPajama ‘a Data-1T LLM training set.
Clients continually contact Mobilunity, asking to find professionals skilled in generativeAI, NLP, and chatbots. Prompt engineering is critical for refining and trainingAI models as GenAI experts analyze misinterpretations, gaps, or patterns in models’ results. Highlight training opportunities.
AI Open-source generativeAI company Together AI provides infrastructure to train models. Healthcare and Biotech IntraBio , a biopharmaceutical company developing treatments for neurodegenerative diseases raised a further $40 million in funding at a value of $1 billion.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content